Sputtr.com | Alternative Search Engine

Genentech

Genentech 2007 Corporate Sustainability Report

CEO Message 1 Arthur D. Levinson, Ph. D. Chairman and CEO I am pleased to introduce our third Corporate Sustainability Report, in which we describe the status of our efforts to protect natural resources and our employees' health, safety and wellness, while delivering our mission of addressing ...

STATEMENT OF MEDICAL NECESSITY (SMN) for Genentech ...

Last name*: _____First name*: _____ Birth date*: _____ Reminder: Genentech BioOncology Access Solutions cannot work with the insurance plan on your patient's behalf without a physician's signature and date, as well as a ...

Genentech: New Energy Efficient Pharmaceutical Manufacturing ...

Supersymmetry Page 1 CIEE Cleanroom Case Studies: Genentech Genentech: New Energy Efficient Pharmaceutical Manufacturing Cleanroom Facility 1 Project Benefits Summary Estimated Annual Energy Cost Savings $552,800/y Actual Incremental Project Cost $1,783,360 Utility Incentive $842,400 Project ...

Patient Assistance Form

Yes No If Yes, Date of First Treatment: Number of Doses Planned: Dose: mg Frequency of Administration: Concurrent Treatment Prescribed With Genentech Product: Is Patient Deceased?

What It Takes To Be #1 in America List

© 2006 Great Place to Work ® Institute, Inc. All rights reserved. Page 1 Genentech, a biotechnology pioneer, tops this year’s 100 Best list for a number of

PATIENT AUTHORIZATION AND NOTICE OF RELEASE OF INFORMATION ...

Genentech BioOncology Access Solutions is a free program for you from Genentech. We work to help you pay for your Genentech product. We can help in many different ways.

Backgrounder - Overview

Page 1 of 5 Backgrounder Media Contact: Geoffrey Teeter (650) 225-8171 Genentech Overview Founded more than 35 years ago, Genentech is a leading biotechnology company that

Alteplase (CathFlo Activase), Genentech, Package Insert

Cathflo Activase [Alteplase] Cathflo Activase 2 [Alteplase] 3 Powder for reconstitution for use in central venous access 4 devices 5 DESCRIPTION 6 Cathflo Activase [Alteplase] is a tissue plasminogen activator (t-PA) 7 produced by recombinant DNA technology.

Patient Assistance Form

I agree that Genentech and its agents may contact me in the futurebymail, e-mail, and/or telephone concerning the Cancer Connectionsprogram. I understand that all personally identifiable information will be kept strictly confidential and will not be distributed outside of Genentech or its agents, as ...

Genentech, UC Settle Suit for $200 Million

Science 26 November 1999: Vol. 286. no. 5445, p. 1655 DOI: 10.1126/science. 286.5445.1655 a NEWS OF THE WEEK BIOTECH PATENTS: Genentech, UC Settle Suit for $200 Million Marcia Barinaga SAN FRANCISCO-- A bitter episode in biotech history was finally put to rest last week when South San Francisco ...